In the last trading session, 6.11 million shares of the Oscar Health Inc (NYSE:OSCR) were traded, and its beta was 1.61. Most recently the company’s share price was $14.87, and it changed around -$0.57 or -3.69% from the last close, which brings the market valuation of the company to $3.54B. OSCR currently trades at a discount to its 52-week high of $23.79, offering almost -59.99% off that amount. The share price’s 52-week low was $6.93, which indicates that the current value has risen by an impressive 53.4% since then. We note from Oscar Health Inc’s average daily trading volume that its 10-day average is 7.0 million shares, with the 3-month average coming to 3.50 million.
Oscar Health Inc stock received a consensus recommendation rating of Buy, based on a mean score of 2.00. If we narrow it down even further, the data shows that 0 out of 8 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 1 recommended OSCR as a Hold, whereas 4 deemed it a Buy, and 1 rated it as Underweight. Oscar Health Inc is expected to report earnings per share of -0.56 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Oscar Health Inc (NYSE:OSCR) trade information
Instantly OSCR has showed a red trend with a performance of -3.69% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 16.80 on recent trading dayincreased the stock’s daily price by 11.49%. The company’s shares are currently up 62.51% year-to-date, but still up 9.82% over the last five days. On the other hand, Oscar Health Inc (NYSE:OSCR) is -11.49% down in the 30-day period. We can see from the shorts that 12.41 million shares have been sold at a short interest cover period of 4.36 day(s).
The consensus price target as assigned by Wall Street analysts is $21, which translates to bulls needing to increase their stock price by 29.19% from its current value. Analyst projections state that OSCR is forecast to be at a low of $5 and a high of $28.
Oscar Health Inc (OSCR) estimates and forecasts
Oscar Health Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -33.97 percent over the past six months and at a 99.18% annual growth rate that is well above the industry average of 11.10%. The year-over-year growth rate is expected to be 57.97%, up from the previous year.
Consensus estimates provided by 4 financial analysts predict the company will bring in an average of 2.48B in revenue for the current quarter. 3 analysts expect Oscar Health Inc to make 2.78B in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 1.43B and 2.14B respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 73.22%. Forecasts for the next quarter put sales growth at 29.79%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -2.85%. Oscar Health Inc earnings are expected to increase by 104.40% in 2024, but the outlook is positive 71.00% per year for the next five years.
OSCR Dividends
Oscar Health Inc’s next quarterly earnings report is expected to be released in December.
Oscar Health Inc (NYSE:OSCR)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 3.02% of Oscar Health Inc shares, and 85.56% of them are in the hands of institutional investors. The stock currently has a share float of 88.22%. Oscar Health Inc stock is held by 381.0 institutions, with VANGUARD GROUP INC being the largest institutional investor. By 2024-06-30, it held 7.5114% of the shares, which is about 17.38 million shares worth $275.03 million.
BLACKROCK INC., with 6.1246% or 14.18 million shares worth $224.25 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
